These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 19602073)

  • 1. Gadolinium-induced nephrogenic systemic fibrosis is associated with insoluble Gd deposits in tissues: in vivo transmetallation confirmed by microanalysis.
    Thakral C; Abraham JL
    J Cutan Pathol; 2009 Dec; 36(12):1244-54. PubMed ID: 19602073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis.
    Abraham JL; Thakral C; Skov L; Rossen K; Marckmann P
    Br J Dermatol; 2008 Feb; 158(2):273-80. PubMed ID: 18067485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated scanning electron microscopy and x-ray microanalysis for in situ quantification of gadolinium deposits in skin.
    Thakral C; Abraham JL
    J Electron Microsc (Tokyo); 2007 Oct; 56(5):181-7. PubMed ID: 17951398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis--an autopsy-based review.
    Sanyal S; Marckmann P; Scherer S; Abraham JL
    Nephrol Dial Transplant; 2011 Nov; 26(11):3616-26. PubMed ID: 21441397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrogenic systemic fibrosis: histology and gadolinium detection.
    Thakral C; Abraham JL
    Radiol Clin North Am; 2009 Sep; 47(5):841-53, vi-vii. PubMed ID: 19744599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
    Boyd AS; Sanyal S; Abraham JL
    J Am Acad Dermatol; 2010 Feb; 62(2):337-42. PubMed ID: 19939504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of osseous metaplasia in localized cutaneous nephrogenic systemic fibrosis: a case report.
    Wiedemeyer K; Kutzner H; Abraham JL; Thakral C; Carlson JA; Tran TA; Hausser I; Hartschuh W
    Am J Dermatopathol; 2009 Oct; 31(7):674-81. PubMed ID: 19633532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis.
    High WA; Ayers RA; Chandler J; Zito G; Cowper SE
    J Am Acad Dermatol; 2007 Jan; 56(1):21-6. PubMed ID: 17097388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent decrement of dermal gadolinium deposits and significant improvement of skin symptoms in a patient with nephrogenic systemic fibrosis after temporary renal failure.
    Schäd SG; Heitland P; Kühn-Velten WN; Gross GE; Jonas L
    J Cutan Pathol; 2013 Nov; 40(11):935-44. PubMed ID: 24102613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrogenic systemic fibrosis: more questions and some answers.
    Morcos SK; Thomsen HS
    Nephron Clin Pract; 2008; 110(1):c24-31; discussion c32. PubMed ID: 18688172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmetallation and gadolinium: do low iron stores prevent the development of nephrogenic systemic fibrosis in high-risk end-stage renal disease patients?
    Panesar M; Boateng F; Patel SS; Masood SF; Mahajan P; Patel N; Murray B
    Hemodial Int; 2010 Jul; 14(3):289-94. PubMed ID: 20662951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
    Broome DR
    Eur J Radiol; 2008 May; 66(2):230-4. PubMed ID: 18372138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of gadolinium contrast agents in naïve and nephrectomized rats: relevance to nephrogenic systemic fibrosis.
    Grant D; Johnsen H; Juelsrud A; Løvhaug D
    Acta Radiol; 2009 Mar; 50(2):156-69. PubMed ID: 19160079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis - a mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide.
    Steger-Hartmann T; Raschke M; Riefke B; Pietsch H; Sieber MA; Walter J
    Exp Toxicol Pathol; 2009 Nov; 61(6):537-52. PubMed ID: 19131226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury.
    Kalb RE; Helm TN; Sperry H; Thakral C; Abraham JL; Kanal E
    Br J Dermatol; 2008 Mar; 158(3):607-10. PubMed ID: 18076707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting nephrogenic systemic fibrosis in 6 kidney transplant recipients: a single-center experience.
    Lemy AA; del Marmol V; Kolivras A; High WA; Matos C; Laporte M; Nortier JL
    J Am Acad Dermatol; 2010 Sep; 63(3):389-99. PubMed ID: 20619488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis.
    Abraham JL; Thakral C
    Eur J Radiol; 2008 May; 66(2):200-7. PubMed ID: 18374532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness.
    Canavese C; Mereu MC; Aime S; Lazzarich E; Fenoglio R; Quaglia M; Stratta P
    J Nephrol; 2008; 21(3):324-36. PubMed ID: 18587720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchrotron X-ray analyses demonstrate phosphate-bound gadolinium in skin in nephrogenic systemic fibrosis.
    George SJ; Webb SM; Abraham JL; Cramer SP
    Br J Dermatol; 2010 Nov; 163(5):1077-81. PubMed ID: 20560953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadolinium deposition in nephrogenic fibrosing dermopathy.
    Boyd AS; Zic JA; Abraham JL
    J Am Acad Dermatol; 2007 Jan; 56(1):27-30. PubMed ID: 17109993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.